More than 125 million people face severe weather risks as tornado watches are issued across the Central U.S. while Hawaii deals with storm aftermath.
A Florida doctor faces manslaughter charges after allegedly removing a patient's liver instead of spleen during surgery, resulting in the patient's death.
New research published in the Journal of Studies on Alcohol and Drugs suggests Americans should limit alcohol consumption to one drink per day.
Three people died and 18 first responders were hospitalized after exposure to an unidentified substance during a suspected overdose call in Mountainair, New Mexico.
The FDA approved Regeneron's Otarmeni, the first gene therapy for genetic hearing loss, as the company agreed to a drug pricing deal with the Trump administration.
Pfizer's experimental monthly obesity injection demonstrated a side effect profile comparable to existing GLP-1 drugs in mid-stage trials.
A meningitis outbreak in Kent has resulted in two deaths and cases at multiple educational institutions, prompting health authorities to distribute antibiotics.
A suspect in the death of a five-year-old Aboriginal girl was transferred from Alice Springs to Darwin following his arrest and subsequent community unrest.
The Department of Justice announced civil rights investigations into 15 medical schools examining potential racial discrimination in admissions processes.
Two Ohio state employees and two co-conspirators face charges for allegedly billing Medicaid for children's behavioral health services never provided.
Health officials are tracking an Ebola outbreak in Central Africa as an American doctor is evacuated to Berlin for treatment.
The nation's largest health insurer will remove approval requirements for select treatments and procedures.
President Trump has introduced new pharmaceutical pricing programs, including TrumpRx discount coupons, while industry consolidation proceeds with major acquisitions.
New research suggests GLP-1 medications may slow cancer progression while bariatric surgery rates drop.
A pill version of Novo Nordisk's obesity drug Wegovy has generated a waiting list of 10,000 people in the United Kingdom.
Page 6 of 42 (620 stories)